KOE · 115450.KQ
HLB Therapeutics Co.,Ltd.
₩2,505-₩55 (-2.15%)
HLB Therapeutics Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 39.78% below the high.
Loading market information…
KOE · 065660.KQ · KRW
Stock price, earnings
Quote as of Oct 30, 2026, 05:24 AM UTC. Cached market data; not a live quote.
One-year closing-price history · KRW. Historical prices are not a forecast.
Anterogen.Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 78.28% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Anterogen.Co.,Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Anterogen.Co.,Ltd., a South Korean bio-venture founded in 2000 and headquartered in Seoul, specializes in the global research, development, and commercialization of therapeutic products utilizing adipose-derived stem cells. Their pharmaceutical offerings include Cupistem injection, an adipose stem cell product for treating Crohn's fistula; Queencell, a stromal vascular fraction aimed at regenerating subcutaneous adipose tissue; and Remodulin injection, which addresses pulmonary arterial hypertension. The company also produces a line of cosmetics, featuring SCM2 and SCM2-Black for hair care, and Therastem-Derma, Therastem-White Silk, and Therastem-White Glutathione for skin care, along with providing human stem cell conditioned media as a cosmetic raw material. Furthermore, Anterogen offers services such as cell banking and various analytical services, including sample analysis for clinical studies and biopharmaceutical testing for identification, purity, potency, and adventitious viruses.
Latest available per-share figures in KRW. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:46 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₩2,505-₩55 (-2.15%)
HLB Therapeutics Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 39.78% below the high.
₩5,810-₩110 (-1.86%)
JETEMA, Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 48.49% below the high.
₩6,860-₩120 (-1.72%)
Bioneer Corporation’s quoted price sits in the lower half of its reported 52-week range, 61.78% below the high.
₩5,250-₩100 (-1.87%)
EASY BIO,Inc.’s quoted price sits in the lower half of its reported 52-week range, 38.67% below the high.
₩3,680+₩60 (+1.66%)
Helixmith Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 63.05% below the high.
₩10,860-₩90 (-0.82%)
Macrogen, Inc.’s quoted price sits in the lower half of its reported 52-week range, 48.04% below the high.
₩2,160-₩5 (-0.23%)
Genexine, Inc.’s quoted price sits in the lower half of its reported 52-week range, 71.09% below the high.
₩915+₩9 (+0.99%)
Amicogen, Inc.’s quoted price sits in the lower half of its reported 52-week range, 71.8% below the high.
